One-day event in Beijing convened more than 400 leaders from government, academia and industry to discuss precision medicine advancement
BEIJING, March 29, 2018 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today sponsored the first China-U.S. Precision Medicine Summit, along with co-hosts CEO Roundtable on Cancer, China Academy of Medical Sciences and Peking Union Medical College. The Summit convened more than 400 leaders from across government, academia and industry to promote partnership and collaboration that will lead to advances in the prevention, diagnosis and treatment of disease.
Both the U.S. and China are committed to policies and investment that accelerate the adoption of precision medicine globally. In China, precision medicine is a prominent part of the 13th Five-Year Plan, which sets an ambitious roadmap and budget. The Summit, “Transforming Lives through Pioneering Precision Medicine,” featured distinguished speakers from both countries, including representatives from the U.S. National Institutes of Health, Ruijin Hospital, Shanghai Jiaotong University and the China Food and Drug Administration. The U.S. Ambassador to China, Terry Branstad, was also in attendance, and discussed critical topics in precision medicine from the perspectives of policy, research and clinical applications. He called for action to increase collaboration between China and the U.S., as well as across industry in China.
“Our collective goal is to deepen conversations and share insights to improve current cancer therapies and address unmet medical needs,” said Dr. Martin Murphy, Chief Executive Officer of CEO Roundtable on Cancer. “More importantly, the Summit serves as a great opportunity for us to learn from each other and foster collaboration in battling together to end cancer.”
As the event sponsor, Thermo Fisher provided a perspective on the importance of precision medicine in developing new patient care models and advancing healthcare economics. “We actively support governments, academia, pharma/biotech and clinicians with technology and expertise to accelerate precision medicine research, with a pathway to the clinic,” said Mark Stevenson, executive vice president and chief operating officer of Thermo Fisher Scientific. “The Summit enables the exchange of ideas that will lead to improved patient outcomes and lower the cost of care.”
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.
Media Contact Information:
Ron O’Brien
Phone: 781-622-1242
Email: Ron.obrien@thermofisher.com
SOURCE Thermo Fisher Scientific